[HTML][HTML] TMBur: a distributable tumor mutation burden approach for whole genome sequencing

E Titmuss, RD Corbett, S Davidson, S Abbasi… - BMC Medical …, 2022 - Springer
Background Tumor mutation burden (TMB) is a key characteristic used in a tumor-type
agnostic context to inform the use of immune checkpoint inhibitors (ICI). Accurate and …

[HTML][HTML] TMBur: a distributable tumor mutation burden approach for whole genome sequencing

E Titmuss, RD Corbett… - BMC Medical …, 2022 - bmcmedgenomics.biomedcentral …
Tumor mutation burden (TMB) is a key characteristic used in a tumor-type agnostic context to
inform the use of immune checkpoint inhibitors (ICI). Accurate and consistent measurement …

TMBur: a distributable tumor mutation burden approach for whole genome sequencing

E Titmuss, RD Corbett, S Davidson… - BMC Medical …, 2022 - search.proquest.com
Background Tumor mutation burden (TMB) is a key characteristic used in a tumor-type
agnostic context to inform the use of immune checkpoint inhibitors (ICI). Accurate and …

[HTML][HTML] TMBur: a distributable tumor mutation burden approach for whole genome sequencing

E Titmuss, RD Corbett, S Davidson, S Abbasi… - BMC Medical …, 2022 - ncbi.nlm.nih.gov
Background Tumor mutation burden (TMB) is a key characteristic used in a tumor-type
agnostic context to inform the use of immune checkpoint inhibitors (ICI). Accurate and …

TMBur: a distributable tumor mutation burden approach for whole genome sequencing.

E Titmuss, RD Corbett, S Davidson, S Abbasi… - BMC Medical …, 2022 - europepmc.org
Background Tumor mutation burden (TMB) is a key characteristic used in a tumor-type
agnostic context to inform the use of immune checkpoint inhibitors (ICI). Accurate and …

[HTML][HTML] TMBur: a distributable tumor mutation burden approach for whole genome sequencing.

E Titmuss, RD Corbett, S Davidson, S Abbasi… - library.dctabudhabi.ae
Background: Tumor mutation burden (TMB) is a key characteristic used in a tumor-type
agnostic context to inform the use of immune checkpoint inhibitors (ICI). Accurate and …

TMBur: a distributable tumor mutation burden approach for whole genome sequencing

E Titmuss, RD Corbett, S Davidson, S Abbasi… - 2022 - open.library.ubc.ca
Background Tumor mutation burden (TMB) is a key characteristic used in a tumor-type
agnostic context to inform the use of immune checkpoint inhibitors (ICI). Accurate and …

TMBur: a distributable tumor mutation burden approach for whole genome sequencing.

E Titmuss, RD Corbett, S Davidson… - BMC Medical …, 2022 - search.ebscohost.com
Background: Tumor mutation burden (TMB) is a key characteristic used in a tumor-type
agnostic context to inform the use of immune checkpoint inhibitors (ICI). Accurate and …

TMBur: a distributable tumor mutation burden approach for whole genome sequencing

E Titmuss, RD Corbett, S Davidson… - BMC medical …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Tumor mutation burden (TMB) is a key characteristic used in a tumor-type
agnostic context to inform the use of immune checkpoint inhibitors (ICI). Accurate and …

[PDF][PDF] TMBur: a distributable tumor mutation burden approach for whole genome sequencing

E Titmuss, RD Corbett, S Davidson, S Abbasi… - 2022 - bmcmedgenomics.biomedcentral …
Background: Tumor mutation burden (TMB) is a key characteristic used in a tumor-type
agnostic context to inform the use of immune checkpoint inhibitors (ICI). Accurate and …